The Largest E-Cigarette Seizure in U.S. History: 4.7 Million Illegal E-Cigarettes Confiscated, With a Retail Value of Approximately $86.5 Million

Sep.11.2025
The Largest E-Cigarette Seizure in U.S. History: 4.7 Million Illegal E-Cigarettes Confiscated, With a Retail Value of Approximately $86.5 Million
In a joint operation in Chicago, the U.S. FDA and CBP seized over 4 million illegal e-cigarettes, valued at approximately $86.5 million, marking the largest case in history. The operation is part of the U.S. strategy to combat youth vaping and has named 37 importers for accountability. So far this year, U.S. authorities have intercepted more than 6 million illegal e-cigarettes, with a total value exceeding $120 million.

Key Takeaways

 

Record Seizure: In a joint operation in Chicago, the FDA and CBP seized over 4 million unauthorized e-cigarettes, with a retail value exceeding $86 million — the largest case in U.S. history.

 

Operation Timeline: The enforcement action lasted one week and was coordinated across multiple federal agencies.

 

Enforcement Focus: Authorities targeted FDA authorization compliance, tax evasion, intellectual property violations, and hazardous materials labeling issues.

 

Strategic Significance: The operation is part of the FDA’s broader strategy to curb youth vaping, including preventing “port-hopping” loopholes, cleaning up distribution networks, strengthening parental education, and tightening retail oversight.

 

Year-to-Date Results: As of 2025, the FDA and CBP have intercepted more than 6 million illegal e-cigarettes, with a total value exceeding $120 million.

 

Aftermath: All seized products lack FDA marketing authorization and cannot be legally sold or distributed. The 37 importers involved have been publicly named and must respond within 30 days.

 


 

2Firsts, Sept. 10 —On September 10 local time, the U.S. Food and Drug Administration (FDA) and U.S. Customs and Border Protection (CBP) jointly announced that, during a weeklong enforcement operation, they seized more than 4 million units of unauthorized e-cigarette products with an estimated retail value exceeding $86 million (approximately 627 million RMB). This marks the largest seizure of its kind in U.S. history. The operation, conducted in Chicago, was aimed at inspecting incoming shipments and preventing illegal e-cigarettes from entering the U.S. market.

 

The Largest E-Cigarette Seizure in U.S. History: 4.7 Million Illegal E-Cigarettes Confiscated, With a Retail Value of Approximately $86.5 Million
Seized E-Cigarettes | Source: CBP

 

The operation, which was the culmination of months of planning and interagency coordination, targeted incoming shipments suspected of containing unauthorized e-cigarettes. Nearly all of the seized products originated in China and were destined for distribution across the United States. In total, approximately 4.7 million e-cigarette units were intercepted, with a manufacturer’s suggested retail price (MSRP) valued at more than $86.5 million.

 

During the inspections, enforcement teams identified multiple violations, including the absence of FDA marketing authorization, federal revenue evasion, trademark infringements, and improper hazardous materials labeling.

 

“Parents, teachers, coaches, and others concerned about our kids should be alarmed by how many unauthorized e-cigarettes have been seized,” said CBP Commissioner Rodney Scott. “There is no telling what dangers are inside these products or the conditions under which they were made. I urge everyone to know what they are buying.”

 

This enforcement action is part of the FDA’s broader strategy to curb youth vaping, which includes eliminating “port shopping,” disrupting illegal distribution networks, educating parents on vaping risks, and ensuring nationwide retail compliance.

 

“We will never allow foreign actors to threaten the health of America’s children,” said Health and Human Services Secretary Robert F. Kennedy, Jr. “Today we took decisive action to protect kids from illegal vape products. I thank President Trump and Attorney General Bondi for their leadership in shutting down this black market.”

“The FDA and our federal partners are committed to securing America’s borders and preventing illegal vaping products from entering the country,” said FDA Commissioner Marty Makary, M.D., M.P.H. “If a product has not been authorized by the FDA, CBP will seize, detain, or destroy it. Americans—especially our children—should not be exposed to these potentially dangerous, addictive products.”

 

Since the beginning of 2025, CBP and FDA have jointly prevented more than 6 million unauthorized e-cigarette products, with a total MSRP value of over $120 million, from entering the U.S.

 

All e-cigarette products seized in this operation lacked the FDA’s mandatory premarket authorization and therefore cannot be legally marketed or distributed in the United States. To date, the FDA has authorized only 39 e-cigarette products and devices, which are listed in the agency’s Searchable Tobacco Products Database.

 

In addition to product seizures, the FDA issued letters to 37 importers and entry filers responsible for attempting to bring in these unauthorized products. The letters remind firms of their legal obligations, warn that false import statements constitute a federal crime, and require responses within 30 days.

 

JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom heated-tobacco volumes rose 43.5% in the first half of 2026, while combustibles still represented about 97% of its tobacco volume and remained the main earnings base. In Japan, reduced-risk products now account for 48.7% of industry shipments, shifting competition from category adoption towards brand share, pricing and consumer retention. JT’s results offer a revealing case of a traditional tobacco company pursuing a prolonged, dual-track transformation.
JTI
Jul.30
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
Philip Morris International’s second-quarter net revenues rose 10.4% to a record $11.19 billion, as heated tobacco and e-vapor expanded across international markets. IQOS remained the main smoke-free growth engine, while VEEV shipments jumped 55.1%. In the United States, however, ZYN shipments increased just 1.8% and consumer offtake was broadly flat to slightly higher. Cigarette volumes also rose, showing that PMI’s transformation is advancing, but growth is becoming increasingly uneven across categories and markets.
PMI
Jul.22
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08